FDA Issues Alert on Compounded Topical Finasteride Risks ...Middle East

There is no FDA-approved topical formulation of finasteride, and compounded topical finasteride products do not have FDA-approved labeling. The topical products have potentially serious risks. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Issues Alert on Compounded Topical Finasteride Risks )

Also on site :

• Omani Minister of Commerce: Omani-Russian relations witness qualitative leap
• Pedestrian fatally struck by Metra BNSF train in west suburbs
• PHOTO COLLECTION: China Auto Show